Labeling for Biosimilar Products Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 18, 2018
April 24, 2020
e13343b3-e9e8-436e-9bcc-ec73cae4d41c
Related Documents
Referencing Approved Drug Products in ANDA Submissions Guidance for Industry
Guidance DocumentOctober 27, 2020Center for Drug Evaluation and Research
Homeopathic Drug Products Guidance for FDA Staff and Industry
Guidance DocumentDecember 7, 2022Center for Drug Evaluation and Research
Elemental Impurities in Drug Products Guidance for Industry
Guidance DocumentAugust 8, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox